Diagnosis and treatment of CD20 negative B cell lymphomas.

Biomark Res

Division of Hematology & Oncology, New York Medical College and Westchester Medical Center, Valhalla, NY 10595 USA.

Published: February 2017

CD20 negative B cell non-Hodgkin lymphoma (NHL) is rare and accounts for approximately 1-2% of B cell lymphomas. CD20- negative NHL is frequently associated with extranodal involvement, atypical morphology, aggressive clinical behaviour, resistance to standard chemotherapy and poor prognosis. The most common types of these include plasmablastic lymphoma, primary effusion lymphoma, large B-cell lymphoma arising from HHV8-associated multicentric Castleman's disease, and ALK+ large B cell lymphoma. This review provides an overview of the diagnostic and treatment modalities for CD20 negative B cell NHL.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297138PMC
http://dx.doi.org/10.1186/s40364-017-0088-5DOI Listing

Publication Analysis

Top Keywords

cd20 negative
12
negative cell
12
cell lymphomas
8
cell
5
lymphoma
5
diagnosis treatment
4
treatment cd20
4
negative
4
lymphomas cd20
4
cell non-hodgkin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!